New players critical for breast cancer

作     者：Hua Lu 

作者机构：Department of Biochemistry & Molecular Biology and Tulane Cancer Center Tulane University School of Medicine New Orleans LA 70112 USA 

出 版 物：《Journal of Molecular Cell Biology》 (分子细胞生物学报（英文版）)

年 卷 期：2018年第10卷第4期

页      面：271-272页

核心收录：

学科分类：0832[工学-食品科学与工程（可授工学、农学学位）] 083002[工学-环境工程] 0830[工学-环境科学与工程（可授工学、理学、农学学位）] 07[理学] 08[工学] 09[农学] 0903[农学-农业资源与环境] 083203[工学-农产品加工及贮藏工程] 0713[理学-生态学] 

主　　题：癌症 播放器 应用程序开发 雌激素受体 乳 世界范围 种子类型 生长因素 

摘      要：Breast cancer （BC） is the most malignant cancer and the second leading cause of deaths in women worldwide. It is typically classified into the following three subtypes： estrogen receptor （ER）/progesterone receptor （PR）-positive （luminal）, human epidermal growth factor receptor 2 （HER2）-amplified, and ER/PR/HER2-triple negative BC （TNBC）. Tremendous progress has been made to understand molecular mechanisms underlying BC development, progression, and metastasis, and to develop molecule-targeted therapies for clinical applications.